UI Hospitals and Clinics

Studies | Researchers

Clinical Research

Showing newest first. Show oldest first. Or order by title

  1. Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I
    Joseph Cullen MD
  2. An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)
    Daniel Vaena
  3. The Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE Study)
    William Sivitz
  4. A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 with Androgen Deprivation Therapy + Bicalutamide in Patients with Newly Diagnosed Metastatic Hormone Sensitive Prostate Ca…
    Daniel Vaena
  5. A Randomized, Phase III Study of Standard Dosing versus Longer Dosing Interval of Zoledronic Acid in Metastatic Cancer (VAMC)
    Daniel Vaena
  6. ChemoHormonal Therapy versus Androgen Ablation Randomized Trial for Extensive Disease Prostate Cancer (VAMC)
    Daniel Vaena
  7. A Randomized Phase 2 Trial of 177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) with Ketoconazole in Patients with High Risk Castrate Biochemically Relapsed Prostate Cancer After Local Therap…
    Daniel Vaena
  8. A Randomized Phase II Study of NCI Supplied Cabozantinib (NSC #761968 IND #116059) versus weekly paclitaxel (NSC #673089) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube…
    David Bender
  9. A Phase I Study of Intravenous Carboplatin/Paclitaxel or Intravenous and Intraperitoneal Paclitaxel/Cisplatin in Combination with Continuous or Intermittent CTEP-Supplied Agent ABT-888 (NSC #737664, I…
    David Bender
  10. A Pilot Study Targeting Angiogenesis Using Bevacizumab Combined with Chemotherapy and Histone Deacetylase Inhibitor (Valproic Acid) in Advanced Sarcoma (40)
    Mohammed Milhem
  11. An Open-Label, Multicenter, Randomized, Phase III Study to Investigate the Efficacy and Safety of Bendamustine Compared with Bendamustine + RO5072759 (GA101) in Patients with Rituximab-Refractory, Ind…
    Brian Link
  12. Cytogenetic Studies in Acute Leukemia
    Daniel Vaena
  13. A Randomized Phase II Trial of Paclitaxel and Carboplatin vs. Bleomycin, Etoposide, and Cisplatin for Newly Diagnosed Advanced Stage and Recurrent Chemo-Naïve Sex Cord-Stromal Tumors of the Ovary
    David Bender
  14. Umbrella Long-Term Follow-Up Protocol
    Ayman El-Sheikh
  15. Defibrotide for Patients with Hepatic Veno-Occlusive Disease (VOD): A Treatment IND Study (Under CFR 312.34)
    Margarida Magalhaes-Silverman
  16. Treatment to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)
    Ayman El-Sheikh
  17. A phase III, open label, randomized, multicenter trial of ofatumumab maintenance treatment versus no further treatment in subjects with relapsed chronic lymphocytic leukemia (CLL) who have responded t…
    Thomas Carter
  18. A Phase III Randomized Trial for Patients with de novo AML using Bortezomib and Sorafenib (IND#114480; NSC# 681239, NSC# 724772) for Patients with High Allelic Ratio FLT3/ITD
    Ayman El-Sheikh
  19. A Long-Term Prospective Observational Safety Study of the Incidence of and Risk Factors for Fibrosing Colonopathy in US Patients with Cystic Fibrosis...
    Richard Ahrens
  20. Treatment of Patients with Newly Diagnosed Standard Risk Lymphoblastic Leukemia (B-ALL) or localized B-Lineage Lymphoblastic Lymphoma (B-LLy)
    Ayman El-Sheikh

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.